Financhill
Back

Lexaria Bioscience Quote, Financials, Valuation and Earnings

Lexaria Bioscience Price Quote

$3.57
-0.01 (-0.28%)
(Updated: May 10, 2024 at 6:55 PM ET)

Lexaria Bioscience Key Stats

Sell
39
Lexaria Bioscience (LEXX) is a Sell

Day range:
$3.42 - $3.81
52-week range:
$0.65 - $6.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
79.68
P/B ratio:
7.07%

Volume:
189.6K
Avg. volume:
208.5K
1-year change:
353.11%
Market cap:
$46.1M
Revenue:
$226.2K
EPS:
$-0.68

How Much Does Lexaria Bioscience Make?

Is Lexaria Bioscience Growing As A Company?

  • What Is Lexaria Bioscience's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 6.24%
  • What Is Lexaria Bioscience's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lexaria Bioscience Stock Price Performance

What Is Lexaria Bioscience 52-Week High & Low?

Lexaria Bioscience Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lexaria Bioscience?

Is Lexaria Bioscience Cash Flow Positive?

  • What Is LEXX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.2M
  • What Is Lexaria Bioscience’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $6.9M
  • What Is Lexaria Bioscience’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$199.1K

Lexaria Bioscience Return On Invested Capital

  • Is Management Doing A Good Job?
    LEXX return on invested capital is -130.3%
  • What Is Lexaria Bioscience Return On Assets?
    ROA measures how assets are converting to revenues and is -117.45%
  • What Is LEXX Return On Equity?
    ROE is a measure of profitability and is -130.3%

Lexaria Bioscience Earnings Date & Stock Price

Lexaria Bioscience Competitors

  • Who Are Lexaria Bioscience's Competitors?
    Below is a list of companies who compete with Lexaria Bioscience or are related in some way:
    • Acasti Pharma Inc (ACST)
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • Sunshine Biopharma Inc (SBFM)
    • Xenon Pharmaceuticals Inc (XENE)

Lexaria Bioscience Dividend Yield

Data Unavailable

Lexaria Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 624.1% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.00
Upside from Last Price: 179.33%

Major Shareholders

  • How many LEXX shares are owned by institutional investors?
    1.3M LEXX shares are owned by institutional investors
  • How many LEXX shares are owned by insiders?
    4.3M LEXX shares are owned by insiders